If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiopharma Cred. Share News (BPCR)

Share Price Information for Biopharma Cred. (BPCR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.874
Bid: 0.876
Ask: 0.884
Change: -0.004 (-0.46%)
Spread: 0.008 (0.913%)
Open: 0.874
High: 0.874
Low: 0.874
Prev. Close: 0.878
BPCR Live PriceLast checked at -
BioPharma Credit is an Investment Trust

To generate long-term shareholder returns, predominantly in the form of sustainable income distributions from exposure to the life sciences industry.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Anglo Asian to restart Gedabek operations on approval

Tue, 26th Sep 2023 21:47

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

----------

Anglo Asian Mining PLC - Copper, gold and silver producer focused on Azerbaijan - Says the final Micon report was delivered on Tuesday to the company and the Government of Azerbaijan. Following the receipt of the report, the Prime Minister of Azerbaijan issued a press release saying that based on the report, the Gedabek plant can gradually restart operations. The restart of operations will take place in accordance with a timetable to be agreed with the Government. Anglo Asian and the government will also work together to implement Micon's recommendations for the Gedabek operation contained in the report.

----------

BSF Enterprise PLC - London-based biotechnology investor - Confirms allotment of 364,739 ordinary shares, constituting the 264,739 second tranche shares and the 100,000 financial PR shares, conditional to trading on the London Stock Exchange's Main Market at an issue price of 17 pence per share. Expects that admission will become effective on Wednesday.

----------

Power Metal Resources PLC - Metals exploration company focused on North America, Africa, and Australia - Hails escalation of high priority uranium target, based on a remote sensing study at its Badger Lake uranium project located in the Athabasca Basin, Saskatchewan, Canada. Says analysis finds distinct similarities between Badger Lake and the Arrow Deposit, owned and operated by Nexgen Energy Ltd. Plans to expedite the planned high-resolution electromagnetic UAV survey over Badger Lake, and reemphasises that the target at Badger Lake is an "extremely attractive exploration target". Chief Executive Officer Sean Wade says: "These findings could not come at a better time for shareholders and serve to highlight the huge potential value inherent in our uranium portfolio and in the Power Metal business model more generally."

----------

Ediston Property Investment Co PLC - London-based real estate investment trust focused on UK commercial property - Says shareholders have approved the sale of EPIC Group's property portfolio to RI UK 1 Ltd, a wholly owned subsidiary of Realty Income, for GBP200.8 million. This is prior to agreed deductions of approximately GBP4.0 million.

----------

Amte Power PLC - London-based lithium-ion and sodium-ion battery cells developer and manufacturer - Says shares were restored to trading on Tuesday in London at 1330 BST. Follows announcement on Monday that Amte would make an announcement regarding the launch of a retail offer following the lifting of the suspension of trading.

----------

Grafenia PLC - Manchester-based printing and software company - Says it will formally change its name to Software Circle PLC "in the coming days", as the relevant paperwork has been filed with Companies House. Adds that a further announcement will be made when the name change is formally effective. Upon the change of name becoming effective, the company's TIDM will change from "GRA" to "SFT". The ISIN and SEDOL numbers will remain unchanged.

----------

Croda International PLC - Yorkshire, England-based chemicals firm - Says Nicholas Ian Challoner, a member of the executive committee, sells 6,339 shares in the company at GBP49.16 each, coming to a total of GBP311,617 in shares.

----------

BioPharma Credit PLC - Specialist life sciences debt investment trust - Notes filing by LumiraDx Ltd, which discloses an amendment to the loan agreement entered into with BioPharma Credit PLC, BPCR Ltd Partnership, and BioPharma Credit Investments V LP. On September 25, LumiraDx entered into a twelfth amendment and waiver to the loan agreement of March 31. This amendment made several stipulations, including that the minimum liquidity covenant in the agreement is waived until October 11, provided that the consolidated liquidity of the company and its subsidiaries during this waiver period must be at least USD5 million, that the minimum net sales covenant for the trailing twelve-month period ended June 30 is waived. BioPharma Credit expects that the USD3.0 million Tranche D loan amount will be funded on Wednesday.

----------

ActiveOps PLC - Reading, England-based management process automation software provider for back-office operations - Launches ControliQ Series 3, a new version of its management process automation product. Says that ControliQ Series 3 has additional artifical intelligence features. Following the official launch in August, customers across multiple geographies and sectors are already using the new capabilities. ActiveOps intends to launch the ControliQ Series 4 in 2024.

----------

By Holly Beveridge, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
24 Oct 2018 09:02

BioPharma Credit increases placing following 'strong investor demand'

(Sharecast News) - BioPharma Credit has increased the size of its proposed placing to "at least" $200m on the back of investor demand that exceeded its original target.

Read more
19 Oct 2018 11:26

BioPharma Credit To Raise USD150 Million Via Placing (ALLISS)

LONDON (Alliance News) - BioPharma Credit PLC said Friday it intends to raise USD150 million via share placing.The company will issue 146.3 million shares at USD1.025 per share, a 2.9% to a

Read more
27 Sep 2018 12:43

BioPharma Credit Interim Net Asset Value Flat, Income Rises Sharply

LONDON (Alliance News) - BioPhamra Credit PLC on Thursday reported a sharp rise in income in the first halfIn the six months ended June, the life sciences debt investment trust increased to

Read more
20 Sep 2018 13:31

BioPharma Credit Loans USD150 Million To Amicus Therapeutics

LONDON (Alliance News) - BioPharma Credit PLC said Thursday that it has loaned USD150 million to Amicus Therapeutics Inc, a rare metabolic disease-focused biopharmaceutical company.Under in

Read more
2 Jul 2018 12:55

BioPharma Funds USD200 Million TESARO Loan Alongside Other Investors

LONDON (Alliance News) - BioPharma Credit PLC said Monday it has funded, alongside other investors, the USD200 million second tranche of a USD500 million loan to TESARO Inc.The company and

Read more
4 May 2018 12:26

Pablo Legorreta Doubles BioPharma Credit Stake To 7.1% (ALLISS)

LONDON (Alliance News) - BioPharma Credit PLC said Friday Pablo Legorreta doubled his stake in the pharmaceutical debt investor in a transaction on Monday.Legorreta - the founder and chief

Read more
2 May 2018 16:51

Pharmaceutical Investors Cuts BioPharma Credit Stake Below 3% (ALLISS)

LONDON (Alliance News) - Life-science focused debt investor BioPharma Credit PLC said on Wednesday Pharmaceutical Investors LP sold shares in the company on Tuesday.After the transaction a

Read more
1 May 2018 16:26

BioPharma Invests USD194 Million In US Pharma Firm Sebela

LONDON (Alliance News) - BioPharma Credit PLC said Tuesday that it has invested USD194 million in a unit of US-based Sebela Pharmaceuticals Inc.The life science-focused debt investor has a

Read more
23 Apr 2018 13:06

BioPharma Credit To Invest USD191 Million In Pharmaceutical Developer

LONDON (Alliance News) - Life science-focused debt investor BioPharma Credit PLC said on Monday it has become the lead investor and collateral agent for a USD315.0 million loan to an unnamed will

Read more
8 Mar 2018 12:21

BioPharma Credit To Raise USD300 Million As Net Asset Value Rises (ALLISS)

LONDON (Alliance News) - Life sciences debt investor BioPharma Credit PLC said Thursday it has had a "highly successful" 2017 and announced a share issue to raise on

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.